AnalystsMatthew LuchiniMatthew Luchini's Stock Forecasts
AnalystsMatthew Luchini
Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4442 out of 4870 analysts
Average Return
-3.16%
Win Rate
31%12 out of 39
Risk vs Reward
Poor
Good
Matthew Luchini's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Kodiak Sciences IncKOD | +226.81% | $47.70 | $155.89 | 2020-03-30 - 2021-01-25 | Buy |
Alder Biopharmaceuticals IncALDR | +117.51% | $8.85 | $19.25 | 2017-08-09 - 2018-08-10 | Buy |
Gamida Cell LtdGMDAQ | +110.81% | $4.44 | $9.36 | 2020-02-25 - 2021-02-26 | Buy |
Alder Biopharmaceuticals IncALDR | +101.04% | $9.65 | $19.40 | 2017-08-08 - 2018-08-09 | Buy |
Apellis Pharmaceuticals IncAPLS | +93.44% | $34.93 | $67.57 | 2021-09-09 - 2022-09-09 | Buy |
Matthew Luchini Analyst Color
Get additional color on Matthew Luchini's coverage of popular stocks
Matthew Luchini's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Replimune Group IncREPL | 1 | Buy | $30.00 | N/A | Maintains | 3 years ago |
Entasis Therapeutics Holdings IncETTX | 1 | Buy | $7.00 | N/A | Maintains | 4 years ago |
Jasper Therapeutics IncJSPR | 1 | Buy | $190.00 | N/A | Initiates Coverage On | 4 years ago |
Ngm Biopharmaceuticals IncNGM | 2 | Buy | $35.00 | N/A | Maintains | 4 years ago |
Apellis Pharmaceuticals IncAPLS | 3 | Buy | $69.00 | N/A | Maintains | 4 years ago |
Kodiak Sciences IncKOD | 3 | Hold | $104.00 | N/A | Maintains | 4 years ago |
C4 Therapeutics IncCCCC | 1 | Buy | $55.00 | N/A | Initiates Coverage On | 4 years ago |
Arvinas IncARVN | 1 | Buy | $101.00 | N/A | Initiates Coverage On | 4 years ago |
Decibel Therapeutics IncDBTX | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Regeneron Pharmaceuticals IncREGN | 7 | Buy | $630.00 | N/A | Upgrades | 4 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $175.00 | N/A | Downgrades | 4 years ago |
Bluebird Bio IncBLUE | 11 | Hold | $1,120.00 | N/A | Downgrades | 4 years ago |
Intercept Pharmaceuticals IncICPT | 2 | Hold | $52.00 | N/A | Downgrades | 5 years ago |
Madrigal Pharmaceuticals IncMDGL | 1 | Hold | $135.00 | N/A | Initiates Coverage On | 5 years ago |
Viking Therapeutics IncVKTX | 1 | Buy | $14.00 | N/A | Initiates Coverage On | 5 years ago |
Gilead Sciences IncGILD | 1 | Hold | $79.00 | N/A | Downgrades | 5 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | $17.00 | N/A | Maintains | 5 years ago |
Nightstar Therapeutics PLCNITE1 | 2 | Hold | $25.50 | N/A | Downgrades | 6 years ago |
Spark Therapeutics IncONCE | 8 | Hold | $114.50 | N/A | Maintains | 6 years ago |
Atyr Pharma IncATYR | 1 | Hold | $14.00 | N/A | Maintains | 7 years ago |
Alder Biopharmaceuticals IncALDR | 4 | Buy | $23.00 | N/A | Maintains | 7 years ago |
Regulus Therapeutics IncRGLS | 4 | Hold | $164.40 | N/A | Maintains | 7 years ago |
Audentes Therapeutics IncBOLD1 | 1 | Buy | $35.00 | N/A | Initiates Coverage On | 7 years ago |
Applied Genetic Technologies CorpAGTC | 1 | Buy | $7.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.